74 related articles for article (PubMed ID: 2325733)
1. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
[TBL] [Abstract][Full Text] [Related]
2. Complement modulates the cutaneous microbiome and inflammatory milieu.
Chehoud C; Rafail S; Tyldsley AS; Seykora JT; Lambris JD; Grice EA
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15061-6. PubMed ID: 23980152
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Genetic Causal Relationships Between Multiple Immune-Mediated Inflammatory Diseases and Age-Related Macular Degeneration: A Univariable and Multivariable Mendelian Randomization Study.
Sha F; Li H; Zhang L; Liang F
Ophthalmol Ther; 2024 Apr; 13(4):955-967. PubMed ID: 38315350
[TBL] [Abstract][Full Text] [Related]
4. Complement C3-Deficiency-Induced Constipation in FVB/N-C3
Song HJ; Kim JE; Jin YJ; Roh YJ; Seol A; Kim TR; Park KH; Park ES; An BS; Yang SY; Seo S; Jo SM; Jung YS; Hwang DY
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958740
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD.
Naschberger E; Flierl C; Huang J; Erkert L; Gamez-Belmonte R; Gonzalez-Acera M; Bober M; Mehnert M; Becker C; Schellerer VS; Britzen-Laurent N; Stürzl M
Front Cell Dev Biol; 2023; 11():1213383. PubMed ID: 37645250
[TBL] [Abstract][Full Text] [Related]
6. A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
Mehta RS; Ali H; Dai Y; Yao B; Overman B; Ratanatharathorn V; Gill S; Socié G; Anderson K; Cahn JY; Mujeebuddin A; Champlin R; Shpall E; Holtan SG; Alousi A
Bone Marrow Transplant; 2023 Sep; 58(9):991-999. PubMed ID: 37202544
[TBL] [Abstract][Full Text] [Related]
7. Retinal drusen counts are increased in inflammatory bowel disease, and with longer disease duration, more complications and associated IgA glomerulonephritis.
Nicklason E; Ham Y; Ng D; Glance S; Abel K; Harraka P; Mack H; Colville D; Savige J
Sci Rep; 2022 Jul; 12(1):11744. PubMed ID: 35817816
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the Enteric Nervous System in the Mid Colon of Complement Component 3 Knockout Mice with Constipation Phenotypes.
Choi YJ; Song HJ; Kim JE; Lee SJ; Jin YJ; Roh YJ; Seol A; Kim HS; Hwang DY
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743302
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of Fecal Microbiota From Complement 3 Knockout Mice With Constipation Phenotypes Contributes to Development of Defecation Delay.
Choi YJ; Kim JE; Lee SJ; Gong JE; Son HJ; Hong JT; Hwang DY
Front Physiol; 2021; 12():650789. PubMed ID: 34349661
[TBL] [Abstract][Full Text] [Related]
10. A Protective and Pathogenic Role for Complement During Acute
Sikorski PM; Commodaro AG; Grigg ME
Front Cell Infect Microbiol; 2021; 11():634610. PubMed ID: 33692968
[TBL] [Abstract][Full Text] [Related]
11. Mucin adsorbed by E. coli can affect neutrophil activation in vitro.
Mikhalchik E; Balabushevich N; Vakhrusheva T; Sokolov A; Baykova J; Rakitina D; Scherbakov P; Gusev S; Gusev A; Kharaeva Z; Bukato O; Pobeguts O
FEBS Open Bio; 2020 Feb; 10(2):180-196. PubMed ID: 31785127
[TBL] [Abstract][Full Text] [Related]
12. Collectin-11 (CL-11) Is a Major Sentinel at Epithelial Surfaces and Key Pattern Recognition Molecule in Complement-Mediated Ischaemic Injury.
Nauser CL; Howard MC; Fanelli G; Farrar CA; Sacks S
Front Immunol; 2018; 9():2023. PubMed ID: 30237800
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis.
Zhao S; Chen Q; Kang X; Kong B; Wang Z
Biomed Res Int; 2018; 2018():2617432. PubMed ID: 30186855
[TBL] [Abstract][Full Text] [Related]
14. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
Asif A; Nayer A; Haas CS
J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
[TBL] [Abstract][Full Text] [Related]
15. A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.
Gupta A; Juyal G; Sood A; Midha V; Yamazaki K; Vich Vila A; Esaki M; Matsui T; Takahashi A; Kubo M; Weersma RK; Thelma BK
Eur J Hum Genet; 2016 Jan; 25(1):111-122. PubMed ID: 27759029
[TBL] [Abstract][Full Text] [Related]
16. A Phase-Variable Surface Layer from the Gut Symbiont Bacteroides thetaiotaomicron.
Taketani M; Donia MS; Jacobson AN; Lambris JD; Fischbach MA
mBio; 2015 Sep; 6(5):e01339-15. PubMed ID: 26419879
[TBL] [Abstract][Full Text] [Related]
17. Do antimicrobial peptides and complement collaborate in the intestinal mucosa?
Kopp ZA; Jain U; Van Limbergen J; Stadnyk AW
Front Immunol; 2015; 6():17. PubMed ID: 25688244
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.
Elvington M; Schepp-Berglind J; Tomlinson S
Clin Exp Immunol; 2015 Mar; 179(3):500-8. PubMed ID: 25293413
[TBL] [Abstract][Full Text] [Related]
19. Clustering Scatter Plots Using Data Depth Measures.
Zhang Z; Cui X; Jeske DR; Li X; Braun J; Borneman J
J Biom Biostat; 2011; Suppl 5():001. PubMed ID: 24883225
[TBL] [Abstract][Full Text] [Related]
20. A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis.
Elvington M; Blichmann P; Qiao F; Scheiber M; Wadsworth C; Luzinov I; Lucero J; Vertegel A; Tomlinson S
Clin Exp Immunol; 2014 Aug; 177(2):500-8. PubMed ID: 24730624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
